discovered that gly‐tRF plays tumor‐promoting role in HCC by targeting NDFIP2 and activating the AKT signaling pathway.[20] However, research on the role of tRFs in HCC is limited. The gene discussed is NDFIP2; the disease is hepatocellular carcinoma.